| Stockholders' Equity |
Shareholders' EquityThe following tables summarize our shareholders’ equity activity for the three and nine months ended September 30, 2026 and 2025, respectively: | | | | | | | | | | Paid-in Capital in Excess of Par Value | | | Accumulated Other Comprehensive Income (Loss) | Noncontrolling Interest in Consolidated Subsidiaries | Total Shareholders' Equity | Balance at December 31, 2025 | | | | | | | | | | | | | | | | | | | | | | | | Other comprehensive income | | | | | | | | Cash dividends ($0.17 per share) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Balance at March 31, 2026 | | | | | | | | | | | | | | | | | | | | | | | | Other comprehensive income | | | | | | | | Cash dividends ($0.17 per share) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Other comprehensive income | | | | | | | | Cash dividends ($0.17 per share) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Balance at September 30, 2026 | | | | | | | |
| | | In the first, second, and third quarters of 2026, we issued common stock from treasury shares for stock options exercised, restricted stock grants, performance shares under our performance unit program, and purchases under our employee stock purchase plan. |
| | | | | | | | | | Paid-in Capital in Excess of Par Value | | | Accumulated Other Comprehensive Income (Loss) | Noncontrolling Interest in Consolidated Subsidiaries | Total Shareholders' Equity | Balance at December 31, 2024 | | | | | | | | Comprehensive income (loss): | | | | | | | | | | | | | | | | Other comprehensive income (loss) | | | | | | | | Cash dividends ($0.17 per share) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Balance at March 31, 2025 | | | | | | | | | | | | | | | | | | | | | | | | Other comprehensive income | | | | | | | | Cash dividends ($0.17 per share) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Other comprehensive income | | | | | | | | Cash dividends ($0.17 per share) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Balance at September 30, 2025 | | | | | | | |
| | | In the first, second, and third quarters of 2025, we issued common stock from treasury shares for stock options exercised, restricted stock grants, performance shares under our performance unit program, and purchases under our employee stock purchase plan. |
Our Board of Directors has authorized a program to repurchase our common stock from time to time. We repurchased 7.3 million shares of our common stock under the program during the three months ended September 30, 2026 for $252 million. Approximately $1.5 billion remained authorized for repurchases under the program as of September 30, 2026. From the inception of this program in February of 2006 through September 30, 2026, we repurchased 342 million shares of our common stock for a total cost of approximately $12.6 billion. We repurchased 11.3 million shares of our common stock under the program during the three months ended September 30, 2025 for approximately $252 million. Accumulated other comprehensive loss consisted of the following: | | | | | | | | | Cumulative translation adjustments | | | Defined benefit and other postretirement liability adjustments | | | | | | Total accumulated other comprehensive loss | | |
|